275 related articles for article (PubMed ID: 20699457)
1. Exposure to oral bisphosphonates and risk of esophageal cancer.
Cardwell CR; Abnet CC; Cantwell MM; Murray LJ
JAMA; 2010 Aug; 304(6):657-63. PubMed ID: 20699457
[TBL] [Abstract][Full Text] [Related]
2. Oral Bisphosphonates and Upper Gastrointestinal Cancer Risks in Asians with Osteoporosis: A Nested Case-Control Study Using National Retrospective Cohort Sample Data from Korea.
Jung SY; Sohn HS; Park EJ; Suh HS; Park JW; Kwon JW
PLoS One; 2016; 11(3):e0150531. PubMed ID: 26937968
[TBL] [Abstract][Full Text] [Related]
3. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort.
Green J; Czanner G; Reeves G; Watson J; Wise L; Beral V
BMJ; 2010 Sep; 341():c4444. PubMed ID: 20813820
[TBL] [Abstract][Full Text] [Related]
4. Exposure to oral bisphosphonates and risk of cancer.
Cardwell CR; Abnet CC; Veal P; Hughes CM; Cantwell MM; Murray LJ
Int J Cancer; 2012 Sep; 131(5):E717-25. PubMed ID: 22161552
[TBL] [Abstract][Full Text] [Related]
5. Oral bisphosphonates and upper gastrointestinal toxicity: a study of cancer and early signals of esophageal injury.
Morden NE; Munson JC; Smith J; Mackenzie TA; Liu SK; Tosteson AN
Osteoporos Int; 2015 Feb; 26(2):663-72. PubMed ID: 25349053
[TBL] [Abstract][Full Text] [Related]
6. Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2013 Jan; 346():f114. PubMed ID: 23325866
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis.
Wright E; Schofield PT; Molokhia M
BMJ Open; 2015 Dec; 5(12):e007133. PubMed ID: 26644118
[TBL] [Abstract][Full Text] [Related]
8. Exposure to oral bisphosphonates and risk of gastrointestinal cancer.
Choi D; Choi S; Chang J; Park SM
Osteoporos Int; 2020 Apr; 31(4):775-782. PubMed ID: 32034451
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate use and gastrointestinal tract cancer risk: meta-analysis of observational studies.
Oh YH; Yoon C; Park SM
World J Gastroenterol; 2012 Oct; 18(40):5779-88. PubMed ID: 23155320
[TBL] [Abstract][Full Text] [Related]
10. Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer.
Spence AD; Busby J; Johnston BT; Baron JA; Hughes CM; Coleman HG; Cardwell CR
Gastroenterology; 2018 Mar; 154(4):849-860.e1. PubMed ID: 29122547
[TBL] [Abstract][Full Text] [Related]
11. Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC).
González CA; Jakszyn P; Pera G; Agudo A; Bingham S; Palli D; Ferrari P; Boeing H; del Giudice G; Plebani M; Carneiro F; Nesi G; Berrino F; Sacerdote C; Tumino R; Panico S; Berglund G; Simán H; Nyrén O; Hallmans G; Martinez C; Dorronsoro M; Barricarte A; Navarro C; Quirós JR; Allen N; Key TJ; Day NE; Linseisen J; Nagel G; Bergmann MM; Overvad K; Jensen MK; Tjonneland A; Olsen A; Bueno-de-Mesquita HB; Ocke M; Peeters PH; Numans ME; Clavel-Chapelon F; Boutron-Ruault MC; Trichopoulou A; Psaltopoulou T; Roukos D; Lund E; Hemon B; Kaaks R; Norat T; Riboli E
J Natl Cancer Inst; 2006 Mar; 98(5):345-54. PubMed ID: 16507831
[TBL] [Abstract][Full Text] [Related]
12. Association of Bisphosphonate Use and Risk of Revision After THA: Outcomes From a US Total Joint Replacement Registry.
Khatod M; Inacio MC; Dell RM; Bini SA; Paxton EW; Namba RS
Clin Orthop Relat Res; 2015 Nov; 473(11):3412-20. PubMed ID: 25896134
[TBL] [Abstract][Full Text] [Related]
13. The national-scale cohort study on bisphosphonate-related osteonecrosis of the jaw in Taiwan.
Yuh DY; Chang TH; Huang RY; Chien WC; Lin FG; Fu E
J Dent; 2014 Oct; 42(10):1343-52. PubMed ID: 24907558
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates and risk of upper gastrointestinal cancer--a case control study using the General Practice Research Database (GPRD).
Wright E; Schofield PT; Seed P; Molokhia M
PLoS One; 2012; 7(10):e47616. PubMed ID: 23112825
[TBL] [Abstract][Full Text] [Related]
15. Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort study.
Lyu H; Zhao SS; Zhang L; Wei J; Li X; Li H; Liu Y; Yin P; Norvang V; Yoshida K; Tedeschi SK; Zeng C; Lei G; Tang P; Solomon DH
BMJ; 2023 Apr; 381():e073435. PubMed ID: 37072150
[TBL] [Abstract][Full Text] [Related]
16. Use of oral bisphosphonates and risk of hospital admission with osteonecrosis of the jaw: Large prospective cohort study in UK women.
Wotton CJ; Green J; Brown A; Armstrong MEG; Floud S; Beral V; Reeves GK;
Bone; 2019 Jul; 124():69-74. PubMed ID: 30959190
[TBL] [Abstract][Full Text] [Related]
17. Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis.
Tennis P; Rothman KJ; Bohn RL; Tan H; Zavras A; Laskarides C; Calingaert B; Anthony MS
Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):810-7. PubMed ID: 22711458
[TBL] [Abstract][Full Text] [Related]
18. Comparative risks for cancer associated with use of calcitonin, bisphosphonates or selective estrogen receptor modulators among osteoporosis patients: a population-based cohort study.
Hsiao FY; Hsu WW
Jpn J Clin Oncol; 2017 Oct; 47(10):935-941. PubMed ID: 28981741
[TBL] [Abstract][Full Text] [Related]
19. Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network.
García Rodríguez LA; Soriano-Gabarró M; Vora P; Cea Soriano L
Int J Cancer; 2020 Nov; 147(9):2394-2404. PubMed ID: 32329063
[TBL] [Abstract][Full Text] [Related]
20. Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers.
Vogtmann E; Corley DA; Almers LM; Cardwell CR; Murray LJ; Abnet CC
PLoS One; 2015; 10(10):e0140180. PubMed ID: 26445463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]